What is the share price of Innova Captab Ltd (INNOVACAP) today?
The share price of INNOVACAP as on 18th September 2026 is ₹1179.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Innova Captab Ltd (INNOVACAP) share?
The past returns of Innova Captab Ltd (INNOVACAP) share are- Past 1 week: 2.24%
- Past 1 month: 13.31%
- Past 3 months: 26.46%
- Past 6 months: 67.35%
- Past 1 year: 37.57%
- Past 3 years: N/A%
- Past 5 years: 117.92%
What are the peers or stocks similar to Innova Captab Ltd (INNOVACAP)?
The peers or stocks similar to Innova Captab Ltd (INNOVACAP) include:What is the dividend yield % of Innova Captab Ltd (INNOVACAP) share?
The current dividend yield of Innova Captab Ltd (INNOVACAP) is 0.17.What is the market cap of Innova Captab Ltd (INNOVACAP) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Innova Captab Ltd (INNOVACAP) is ₹6751.40 Cr as of 18th September 2026.What is the 52 week high and low of Innova Captab Ltd (INNOVACAP) share?
The 52-week high of Innova Captab Ltd (INNOVACAP) is ₹1236.10 and the 52-week low is ₹622.What is the PE and PB ratio of Innova Captab Ltd (INNOVACAP) stock?
The P/E (price-to-earnings) ratio of Innova Captab Ltd (INNOVACAP) is 47.91. The P/B (price-to-book) ratio is 6.19.Which sector does Innova Captab Ltd (INNOVACAP) belong to?
Innova Captab Ltd (INNOVACAP) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Innova Captab Ltd (INNOVACAP) shares?
You can directly buy Innova Captab Ltd (INNOVACAP) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Innova Captab Ltd
INNOVACAP Share Price
NSEINNOVACAP Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
INNOVACAP Performance & Key Metrics
INNOVACAP Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 43.83 | 6.19 | 0.17% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.20 | 5.92 | 0.48% |
from 2 analysts
Price Upside
Earnings Growth
Rev. Growth
INNOVACAP Company Profile
Innova Captab Ltd is an integrated pharmaceutical company involved in manufacturing and trading drugs, offering services across R&D, manufacturing, and distribution of generic formulations and branded generics.
INNOVACAP Sentiment Analysis
INNOVACAP Sentiment Analysis
INNOVACAP Stock Summary · May 2026
Strong top‑line momentum underpinned the call, with consolidated FY'26 revenue of INR 1,630 crore and EBITDA rising to INR 250.3 crore, reflecting broad-based volume‑led growth across CDMO and branded generics. Management struck an upbeat, execution‑focused tone, highlighting customer wins, geographic expansion in branded markets, the strategic benefit of recent regulatory credentials, and R&D investments — including a measured, wave‑2 approach to semaglutide — to move into higher value‑added work. They noted meaningful contrast between robust group growth and near‑term operating unevenness as a recently commissioned Jammu site remains underutilized; management reported Jammu is nearing EBITDA breakeven and should start covering fixed costs imminently, which they expect to unlock operating‑leverage benefits as utilization improves. Management also flagged ongoing capital plans to expand Baddi capacity and to commercialize regulated‑market opportunities from the Sharon acquisition, and explained that accounting choices (capitalizing project costs and prior depreciation/finance impact) will support margin expansion. For FY'27 they reiterated a consolidated target of 20%+ revenue growth driven by sustained volume gains.
INNOVACAP Stock Growth Drivers
INNOVACAP Stock Growth Drivers
10Record FY'26 Financial Performance
The company delivered milestone FY'26 results with consolidated revenue of INR 1,630 crore, up 31%
Broad‑Based Segment Growth: CDMO and Branded Generics
Growth in FY'26 was broad‑based across the CDMO and Branded Generics businesses: CDMO revenue reached
INNOVACAP Stock Challenges
INNOVACAP Stock Challenges
4Rising input-cost and geopolitical API-price risk
Management acknowledged that input prices are increasing due to supply-side disruptions and investors flagged a
Realized gross-margin deterioration driven by adverse product mix
The company reported a year‑on‑year gross margin decline and explicitly attributed the deterioration primarily to
INNOVACAP Forecast
INNOVACAP Forecasts
Price
Revenue
Earnings
INNOVACAP Share Price Forecast
INNOVACAP Share Price Forecast
All values in ₹
All values in ₹
INNOVACAP Company Revenue Forecast
INNOVACAP Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
INNOVACAP Stock EPS (Earnings Per Share) Forecast
INNOVACAP Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
INNOVACAP
INNOVACAP
Income
Balance Sheet
Cash Flow
INNOVACAP Income Statement
INNOVACAP Income Statement
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 268.32 | 296.39 | 320.42 | 320.79 | 318.12 | 356.03 | 384.57 | 451.95 | 449.37 | 472.86 | ||||||||||
| Operating & Other expenses | 224.56 | 252.09 | 268.47 | 269.90 | 267.06 | 299.44 | 328.52 | 380.90 | 382.71 | 397.73 | ||||||||||
| EBITDA | 43.76 | 44.30 | 51.95 | 50.89 | 51.06 | 56.59 | 56.05 | 71.05 | 66.66 | 75.13 | ||||||||||
| Depreciation/Amortization | 3.41 | 4.85 | 4.99 | 5.13 | 9.80 | 11.05 | 11.32 | 11.42 | 11.39 | 11.71 | ||||||||||
| PBIT | 40.35 | 39.45 | 46.96 | 45.76 | 41.26 | 45.54 | 44.73 | 59.63 | 55.27 | 63.42 | ||||||||||
| Interest & Other Items | 0.81 | 0.14 | 0.15 | 0.17 | 1.95 | 2.86 | 5.50 | 3.95 | 4.59 | 4.43 | ||||||||||
| PBT | 39.54 | 39.31 | 46.81 | 45.59 | 39.31 | 42.68 | 39.23 | 55.68 | 50.68 | 58.99 | ||||||||||
| Taxes & Other Items | 10.82 | 9.84 | 11.81 | 11.39 | 9.74 | 11.67 | 9.57 | 13.53 | 12.59 | 14.86 | ||||||||||
| Net Income | 28.72 | 29.47 | 35.00 | 34.20 | 29.57 | 31.01 | 29.66 | 42.15 | 38.09 | 44.13 | ||||||||||
| EPS | 5.02 | 5.15 | 6.12 | 5.97 | 5.17 | 5.42 | 5.18 | 7.37 | 6.65 | 7.71 |
INNOVACAP Company Updates
Investor Presentation
INNOVACAP Stock Peers
INNOVACAP Past Performance & Peer Comparison
INNOVACAP Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Innova Captab Ltd | 47.91 | 6.19 | 0.17% |
| Sun Pharmaceutical Industries Ltd | 38.40 | 5.26 | 0.87% |
| Torrent Pharmaceuticals Ltd | 85.10 | 10.47 | 0.70% |
| Zydus Lifesciences Ltd | 22.96 | 3.91 | 0.09% |
INNOVACAP Stock Price Comparison
Compare INNOVACAP with any stock or ETFINNOVACAP Holdings
INNOVACAP Shareholdings
INNOVACAP Promoter Holdings Trend
INNOVACAP Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
INNOVACAP Institutional Holdings Trend
INNOVACAP Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
INNOVACAP Shareholding Pattern
INNOVACAP Shareholding Pattern
INNOVACAP Shareholding History
INNOVACAP Shareholding History
Mutual Funds Invested in INNOVACAP
Mutual Funds Invested in INNOVACAP
No mutual funds holding trends are available
Top 5 Mutual Funds holding Innova Captab Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.6924% | Percentage of the fund’s portfolio invested in the stock 0.60% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 31/84 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.6028% | Percentage of the fund’s portfolio invested in the stock 1.20% | Change in the portfolio weight of the stock over the last 3 months 0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 70/97 (-4) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.0060% | Percentage of the fund’s portfolio invested in the stock 0.43% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 30/76 (0) |
Compare 3-month MF holding change on Screener
smallcases containing INNOVACAP stock
smallcases containing INNOVACAP stock
Looks like this stock is not in any smallcase yet.
INNOVACAP Events
INNOVACAP Events
INNOVACAP Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
INNOVACAP Dividend Trend
No dividend trend available
INNOVACAP Upcoming Dividends
INNOVACAP Upcoming Dividends
No upcoming dividends are available
INNOVACAP Past Dividends
INNOVACAP Past Dividends
Cash Dividend
Ex DateEx DateJan 30, 2026
Dividend/Share
₹2.00
Ex DateEx Date
Jan 30, 2026
INNOVACAP Stock News & Opinions
INNOVACAP Stock News & Opinions
Innova Captab Limited announced that its board of directors has given in-principle approval for the acquisition of land with an estimated investment of Rs 50,00,00,000, according to a filing with the BSE Limited and National Stock Exchange of India Limited on September 3, 2026.
Innova Captab Limited will hold a board meeting on Friday, August 21, 2026, to revise its standalone and consolidated financial statements for the quarter and financial year ended March 31, 2026, following the identification of inadvertent errors in previously adopted financial statements, including those of entities within its group. The trading window for designated persons and their immediate relatives, which was closed from July 1, 2026, and extended on August 13, 2026, will reopen 48 hours after the revised financial statements are declared.
Innova Captab Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for dealing in the company's securities will remain closed for all designated persons and their immediate relatives until 48 hours after the declaration of the revised audited financial statements for the quarter and financial year ended March 31, 2026.
Innova Captab Ltd share price headed higher 5.49% to Rs 1021.45 after the company's net profit rose by 15.89% to Rs 44.13 crore, while revenue from operations improved marginally 5.15% to Rs 470.85 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.56 lakh crore, easing 4.54%. It has marginally improved by 1.41% over last one week and moving up by 14.23% in last one month while the market capitalization of Innova Captab Ltd has inched up 8.47% and 16.71% in the same period respectively. Profit before tax (PBT) of Innova Captab Ltd stood at Rs 58.99 crore in Q2 FY26, jumping 38.21% year-on-year, and rallying 16.40% quarter-on-quarter. EBITDA came in at Rs 71 crore, surging by 49.33% YoY and rising by 11.91% sequentially. Total expenses posted a minor rise of 3.89% to Rs 409.45 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 307.98 crore, rising 17.89% YoY, while employee benefits expense was at Rs 44.79 crore, inching up 5.09% YoY. For the TTM ended FY26, revenue from operations soared by 31.06% to Rs 1630.02 crore, while net profit saw a mild growth of 9.87% to Rs 140.92 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 19351% to Rs 235.5 crore, and PBT rose 10.08% to Rs 188.26 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 116.52 crore in FY26, as against Rs 63.84 crore in FY25. Innova Captab Ltd climbed 7.60% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 2.56% during the same period.
Innova Captab Limited will hold a board meeting on Tuesday, August 11, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and the revised audited standalone financial results for the quarter and financial year ended March 31, 2026, along with related statements, necessitated by an immaterial inadvertent error. The trading window for securities of Innova Captab Limited will reopen 48 hours after the financial results are declared, having been closed since July 1, 2026, for designated persons and their immediate relatives.
Innova Captab announced that the Annual General Meeting(AGM) of the company will be held on 29 June 2026.
Net profit of Innova Captab rose 28.78% to Rs 38.08 crore in the quarter ended March 2026 as against Rs 29.57 crore during the previous quarter ended March 2025. Sales rose 42.28% to Rs 447.80 crore in the quarter ended March 2026 as against Rs 314.74 crore during the previous quarter ended March 2025. For the full year,net profit rose 9.87% to Rs 140.92 crore in the year ended March 2026 as against Rs 128.26 crore during the previous year ended March 2025. Sales rose 31.06% to Rs 1630.02 crore in the year ended March 2026 as against Rs 1243.68 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales447.80314.74 42 1630.021243.68 31 OPM %14.5415.15 -14.9014.97 - PBDT62.0649.11 26 233.44195.80 19 PBT50.6839.31 29 188.26171.02 10 NP38.0829.57 29 140.92128.26 10 Powered by Capital Market - Live
Innova Captab will hold a meeting of the Board of Directors of the Company on 7 May 2026.
Net profit of Innova Captab rose 23.25% to Rs 42.15 crore in the quarter ended December 2025 as against Rs 34.20 crore during the previous quarter ended December 2024. Sales rose 42.29% to Rs 450.29 crore in the quarter ended December 2025 as against Rs 316.46 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales450.29316.46 42 OPM %15.4114.71 - PBDT67.1050.72 32 PBT55.6845.59 22 NP42.1534.20 23 Powered by Capital Market - Live
Innova Captab has incorporated a subsidiary company named Metal Mart on 22 January 2026. The company will hold 70% stake in Metal Mart. Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 31.78%, vs industry avg of 11.76%
Over the last 5 years, market share increased from 0.14% to 0.32%
Over the last 5 years, net income has grown at a yearly rate of 32.52%, vs industry avg of 10.45%